Does NAD+ Work in Skincare? The Molecule vs. the Precursor

NAD+ has surged into the 2026 skincare conversation with press framing it as a multitasking active that could rival retinoids. The cellular biology behind the hype is genuinely compelling. Nicotinamide adenine dinucleotide sits at the center of DNA repair, mitochondrial function, and sirtuin signaling, and its levels fall as skin ages. The problem is the distance between that cellular story and what a serum can deliver to living skin. Pure NAD+ is a large, unstable molecule that barely crosses the epidermis, so applying it topically is largely ineffective on its own. This guide separates the molecule from its precursor, explains where the real evidence sits, and reads the emerging research honestly. ## Key Takeaways - **Topical NAD+ has a delivery problem:** The intact molecule is large, charged, and unstable, so it penetrates the epidermis poorly and is largely ineffective applied on its own. - **Niacinamide is the workhorse:** Skin converts niacinamide into NAD+ intracellularly, and niacinamide at 4 to 5 percent has decades of trial data for barrier, tone, and fine lines. - **The buying heuristic:** Look for NAD+ precursors on the label, not NAD+ itself. Niacinamide, niacin, and nicotinamide riboside are the forms that reach the cell. - **CD38 inhibition is the real frontier:** Pairing NAD+ with inhibitors like quercetin or enoxolone to slow its degradation is mechanistically interesting but not yet validated in skin RCTs. - **The cellular story is real but oversold:** NAD+ genuinely drives DNA repair and sirtuin activity, but cellular relevance is not the same as topical efficacy. ## Why the Cellular Story Got Everyone Excited NAD+ is one of the most consequential small molecules in human biology, functioning as a coenzyme in hundreds of redox reactions and as a substrate for enzymes that maintain cellular integrity. It fuels the PARP family of enzymes that repair DNA damage, including the photodamage that accumulates in sun-exposed skin. It feeds the sirtuins, a class of proteins tied to cellular stress resistance and metabolic regulation. It is also central to mitochondrial energy production, which is why fatigue at the cellular level tracks with NAD+ decline. Skin NAD+ levels fall measurably with age and with ultraviolet exposure. A keratinocyte under chronic UV stress burns through NAD+ repairing damage and running its antioxidant defenses, and the supply does not fully replenish. On paper, this makes NAD+ an obvious target: restore the molecule, restore the repair capacity. That logic is what brands have seized on to position NAD+ as the next anti-aging frontier. The leap that gets made too quickly is from intracellular relevance to topical efficacy. A molecule can be indispensable inside the cell and still be the wrong thing to put in a serum, because the barrier that protects skin is also the barrier that keeps actives out. NAD+ is a textbook case of that gap. ## The Penetration Problem Nobody Mentions on the Label A molecule has to be small and appropriately lipophilic to cross the stratum corneum, and intact NAD+ is neither. NAD+ has a molecular weight above 660 daltons, well beyond the rough 500-dalton ceiling that formulators use as a penetration guideline, and it carries charge, which the lipid-rich barrier actively repels. It is also chemically unstable, degrading in water and with exposure to heat and light, so even the fraction that might reach the surface is prone to breaking down before it does anything. The consequence is that a serum advertising "pure NAD+" is selling a molecule that mostly cannot get to the cells where NAD+ does its work. Some of it sits on the surface. Some degrades in the bottle or on contact with skin. Very little crosses into the living epidermis intact and in a form the cell can use. This is not a controversial claim among formulators; it is the reason the credible products in this space are not built around NAD+ at all. What the marketing does instead is borrow the prestige of the cellular biology and attach it to a delivery system that does not deliver. The fix for that gap is not a better NAD+ molecule. It is a smaller precursor the skin already knows how to convert. ## Niacinamide Is the Intervention That Actually Has the Data Niacinamide is the precursor skin cells convert into NAD+ through the salvage pathway, and unlike NAD+ it penetrates readily and carries one of the deepest clinical evidence bases in cosmetic dermatology. At roughly 4 to 5 percent, niacinamide has controlled-trial support for strengthening the skin barrier, reducing transepidermal water loss, improving uneven tone and hyperpigmentation, and softening fine lines over 8 to 12 weeks of use. It also moderates sebum and calms inflammatory redness, which is why it appears in formulations across nearly every skin concern. The mechanism closes the loop with the NAD+ story rather than competing with it. When you apply niacinamide, the cell takes it up and runs it through the salvage pathway to regenerate NAD+ internally, exactly where the molecule needs to be. You are not trying to push a finished coenzyme through a barrier designed to exclude it. You are supplying the raw material the cell uses to make its own, on its own terms. This is the reframe that matters for a reader standing in front of a shelf. The genuinely useful NAD+ product is, in most cases, a niacinamide product. The active that delivers the benefit is the precursor, and the precursor is cheap, stable, and well studied. The buying heuristic follows directly: look past the NAD+ headline and check whether the formula is built on niacinamide or another usable precursor such as nicotinamide riboside. ## The CD38 Frontier Is Interesting, Not Yet Proven CD38 is an enzyme that consumes NAD+, and because its activity rises with age and inflammation, it has become the target of the most scientifically interesting work in this space. The reasoning is that raising NAD+ availability is only half the problem; the other half is slowing the rate at which it gets degraded. Co-formulating NAD+ or a precursor with a CD38 inhibitor such as quercetin or enoxolone is meant to protect the supply so more of it survives to do useful work. This is a legitimate line of research and a more sophisticated approach than simply loading a serum with intact NAD+. The mechanism is coherent, the targets are real, and the early signals are enough to justify continued study. What it is not, yet, is validated for skin in controlled human trials. The evidence is preliminary, drawn largely from cellular and mechanistic work rather than randomized efficacy studies on visible outcomes, and a responsible read keeps it in the investigational column. For now, the honest position is that CD38 inhibition is where to watch, not where to spend. A product invoking quercetin or enoxolone to stabilize NAD+ is doing something defensible in principle, but the marketing claims about visible results have run far ahead of the published data. Treat the category as promising and unfinished. ## Frequently Asked Questions ### Does topical NAD+ actually penetrate the skin? Poorly. NAD+ is a large, charged, unstable molecule, and the stratum corneum is built to keep exactly those out. Most of an intact NAD+ serum sits on the surface or degrades before reaching living cells, which is why formulators rely on smaller precursors like niacinamide instead. ### Is NAD+ better than niacinamide? No. Niacinamide is the precursor your skin converts into NAD+ inside the cell, and it has the clinical record NAD+ lacks. A niacinamide serum delivers the building block your cells can actually use; a pure NAD+ serum delivers a molecule that mostly cannot get in. ### What does NAD+ do in the skin? Inside the cell, NAD+ powers DNA repair through PARP enzymes, supports mitochondrial energy production, and activates sirtuins involved in cellular maintenance. These functions decline with age. The open question is not whether NAD+ matters to cells, but whether a topical product can raise intracellular NAD+ meaningfully. ### What are CD38 inhibitors and why do they matter for NAD+ serums? CD38 is an enzyme that consumes NAD+ and rises with age and inflammation. Pairing NAD+ with CD38 inhibitors such as quercetin or enoxolone is meant to slow that consumption so more NAD+ survives. The idea is sound in principle, but human skin data is preliminary and not yet from controlled trials. ### Should I buy a NAD+ serum? If the only active is intact NAD+, the value is questionable given the penetration problem. A formula built around niacinamide, or one that combines a precursor with a credible stabilizing system, is the better-evidenced spend. Read the ingredient list for the precursor, not the headline molecule. ## The Bottom Line The NAD+ trend rests on real cellular biology and a marketing leap that the biology does not support. NAD+ matters enormously inside the cell, but the intact molecule is the wrong tool for a serum because it cannot reliably get there. The evidenced intervention is niacinamide, the precursor your skin converts into NAD+ on its own, backed by trial data NAD+ itself does not have. If you want the benefit the NAD+ story promises, reach for a well-formulated niacinamide product at 4 to 5 percent and treat headline NAD+ claims as a reason to read the ingredient list more carefully, not less.